Home/Filings/4/0001214659-17-006081
4//SEC Filing

Friedland Jeffrey 4

Accession 0001214659-17-006081

CIK 0001625288other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:40 PM ET

Size

9.8 KB

Accession

0001214659-17-006081

Insider Transaction Report

Form 4
Period: 2017-10-13
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
  • Other

    Common Stock

    2017-10-13+4,450,4584,450,458 total
  • Other

    Common Stock

    2017-10-13+462,848462,848 total(indirect: By LLC)
  • Other

    Common Stock

    2017-10-1320,000,0000 total(indirect: By Intiva USA Inc.)
  • Other

    Common Stock

    2017-10-13+53,405,50153,405,501 total(indirect: By Intiva USA Inc.)
Footnotes (4)
  • [F1]Surrendered as part of share exchange transaction
  • [F2]Acquired in exchange for all of Intiva USA's shares of Intiva BioPharma Inc.
  • [F3]Acquired in exchange for all of Jeffrey Friedland's shares of Intiva BioPharma Inc.
  • [F4]Acquired in exchange for all of Lane 6552 LLC's shares of Intiva BioPharma Inc.

Issuer

Kinder Holding Corp.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001579962

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:40 PM ET
Size
9.8 KB